DYN Competitors & Alternatives
Compare Dyne Therapeutics Inc with similar stocks in the same industry
Biotechnology
DYN
Main Stock$23.64
Tradestie Score
63
Market Cap
$1.78B
Analyst Upside
+61.8%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$129.89
|
$3.98B | - | 67 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$83.67
|
$3.92B | - | 55 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.40
|
$3.91B | - | 61 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.62
|
$3.83B | - | 56 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$19.60
|
$3.68B | - | 55 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$119.04
|
$3.67B | - | 62 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.97
|
$3.59B | 13.4 | 61 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$25.50
|
$3.58B | 11.9 | 63 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$309.25
|
$3.49B | 41.2 | 64 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.97
|
$3.40B | - | 57 | Compare |
More DYN Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry